Business Description
Ardelyx Inc
NAICS : 325412
SIC : 2834
ISIN : US0396971071
Compare
Compare
Traded in other countries / regions
ARDX.USA41X.GermanyARDX.Mexico IPO Date
2017-10-13Description
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.82 | |||||
| Equity-to-Asset | 0.43 | |||||
| Debt-to-Equity | 0.66 | |||||
| Debt-to-EBITDA | -1.97 | |||||
| Piotroski F-Score | 1/9 | |||||
| Altman Z-Score | 1.38 | |||||
| Beneish M-Score | -2.38 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 88.2 | |||||
| 3-Year EBITDA Growth Rate | 36.1 | |||||
| 3-Year EPS without NRI Growth Rate | 34.1 | |||||
| 3-Year FCF Growth Rate | 23.4 | |||||
| 3-Year Book Growth Rate | -18.9 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 60.37 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 71.75 | |||||
| 9-Day RSI | 65.6 | |||||
| 14-Day RSI | 61.13 | |||||
| 6-1 Month Momentum % | -26.2 | |||||
| 12-1 Month Momentum % | 66.61 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.03 | |||||
| Quick Ratio | 3.87 | |||||
| Cash Ratio | 2.7 | |||||
| Days Inventory | 109.24 | |||||
| Days Sales Outstanding | 53.3 | |||||
| Days Payable | 122.79 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -35.4 | |||||
| Shareholder Yield % | -4.22 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 85.16 | |||||
| Operating Margin % | -25.44 | |||||
| Net Margin % | -28.82 | |||||
| FCF Margin % | -25.54 | |||||
| ROE % | -44.58 | |||||
| ROA % | -22.12 | |||||
| ROIC % | -60.11 | |||||
| 3-Year ROIIC % | 41.85 | |||||
| ROC (Joel Greenblatt) % | -212.43 | |||||
| ROCE % | -20.26 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 5.33 | |||||
| PB Ratio | 8.56 | |||||
| Price-to-Tangible-Book | 9.79 | |||||
| EV-to-EBIT | -26.3 | |||||
| EV-to-EBITDA | -27.24 | |||||
| EV-to-Revenue | 5.74 | |||||
| EV-to-Forward-Revenue | 3.39 | |||||
| EV-to-FCF | -19.89 | |||||
| Price-to-Net-Current-Asset-Value | 21.32 | |||||
| Earnings Yield (Greenblatt) % | -3.8 | |||||
| FCF Yield % | -4.17 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ardelyx Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 230.39 | ||
| EPS (TTM) (€) | -0.288 | ||
| Beta | 1.3 | ||
| Volatility % | 69.35 | ||
| 14-Day RSI | 61.13 | ||
| 14-Day ATR (€) | 0.209025 | ||
| 20-Day SMA (€) | 5.4185 | ||
| 12-1 Month Momentum % | 66.61 | ||
| 52-Week Range (€) | 3.23 - 9.46 | ||
| Shares Outstanding (Mil) | 236.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ardelyx Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ardelyx Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Ardelyx Inc Frequently Asked Questions
What is Ardelyx Inc(STU:41X)'s stock price today?
The current price of STU:41X is €5.97. The 52 week high of STU:41X is €9.46 and 52 week low is €3.23.
When is next earnings date of Ardelyx Inc(STU:41X)?
The next earnings date of Ardelyx Inc(STU:41X) is 2025-02-21 Est..
Does Ardelyx Inc(STU:41X) pay dividends? If so, how much?
Ardelyx Inc(STU:41X) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers